WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997020823) 2-AMINO QUINAZOLINE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/020823    International Application No.:    PCT/EP1996/005067
Publication Date: 12.06.1997 International Filing Date: 18.11.1996
Chapter 2 Demand Filed:    14.06.1997    
IPC:
C07D 239/95 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Schwarzwaldallee 215, CH-4058 Basel (CH) (For All Designated States Except US).
RÜEGER, Heinrich [CH/CH]; (CH) (For US Only).
SCHMIDLIN, Tibur [CH/CH]; (CH) (For US Only).
RIGOLLIER, Pascal [FR/FR]; (FR) (For US Only).
YAMAGUCHI, Yasuchika [JP/CH]; (CH) (For US Only).
TINTELNOT-BLOMLEY, Marina [DE/DE]; (DE) (For US Only).
SCHILLING, Walter [CH/CH]; (CH) (For US Only).
CRISCIONE, Leoluca [IT/CH]; (CH) (For US Only).
MAH, Robert [CA/CH]; (CH) (For US Only)
Inventors: RÜEGER, Heinrich; (CH).
SCHMIDLIN, Tibur; (CH).
RIGOLLIER, Pascal; (FR).
YAMAGUCHI, Yasuchika; (CH).
TINTELNOT-BLOMLEY, Marina; (DE).
SCHILLING, Walter; (CH).
CRISCIONE, Leoluca; (CH).
MAH, Robert; (CH)
Common
Representative:
NOVARTIS AG; Patent and Trademark Dept., Lichtstrasse 35, CH-4002 Basle (CH)
Priority Data:
08/566,378 01.12.1995 US
Title (EN) 2-AMINO QUINAZOLINE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS
(FR) ANTAGONISTES DE RECEPTEURS
Abstract: front page image
(EN)The invention relates to a compound of formula (I) in which the variables are as defined and or a salt or a tautomer thereof; and relates to a method of treatment of disorders or diseases associated with NPY receptor subtype Y5, to pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof and to the manufacture of the compounds of formula (I) or a salt thereof.
(FR)L'invention concerne un composé de la formule (I), dans laquelle les variables sont telles que définies, ainsi qu'un sel ou un tautomère de celui-ci. Elle concerne également une méthode de traitement des troubles et maladies associés au sous-type Y5 du récepteur du neuropeptide Y, des compositions pharmaceutiques comprenant un composé de la formule (I) ou un sel de celui-ci acceptable sur le plan pharmacologique, ainsi que la fabrication des composés de la formule (I) ou d'un sel de ceux-ci.
Designated States: AL, AU, BA, BB, BG, BR, CA, CN, CU, CZ, EE, GE, HU, IL, IS, JP, KP, KR, LC, LK, LR, LT, LV, MG, MK, MN, MX, NO, NZ, PL, RO, SG, SI, SK, TR, TT, UA, US, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)